Methoxsalen Capsules — Class II drug recall D-0260-2024
Terminated recall by Strides Pharma Inc., reported 2024-01-31, distributed nationwide. Failed Dissolution Specifications
| Recall number | D-0260-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Strides Pharma Inc., East Brunswick, NJ, United States |
| Recall initiated | 2023-12-29 |
| Classified | 2024-01-24 |
| Reported by FDA | 2024-01-31 |
| Terminated | 2025-07-01 |
| Distributed | Nationwide (US) |
| Reason classes | specification failure |
| NDC | 64380-0752, 64380-0752-16 |
| Lot numbers | 7253092B |
| Expiration dates | 2025-09-30 |
Product
Methoxsalen Capsules, USP 10mg, 50-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India. Distributed by:Strides Pharma Inc. East Brunswick, NJ 08816, NDC 64380-752-16
Reason for recall
Failed Dissolution Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0260-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.